PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 67 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DENALI ADVISORS LLC | 110,200 | $220,400 | 0.08% |
Orin Green Financial, LLC | 60,150 | $120,300 | 0.06% |
XTX Topco Ltd | 170,878 | $341,756 | 0.06% |
EAM Investors, LLC | 165,631 | $331,262 | 0.06% |
CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $51,948 | 0.03% |
HARBOUR INVESTMENT MANAGEMENT LLC | 10,100 | $20,200 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,790 | $317,580 | 0.01% |
Truvestments Capital LLC | 3,880 | $7,760 | 0.00% |
IHT Wealth Management, LLC | 28,800 | $57,600 | 0.00% |
Virtu Financial LLC | 12,108 | $24 | 0.00% |
NATIXIS | 132,000 | $264,000 | 0.00% |
MARSHALL WACE, LLP | 562,139 | $1,124,278 | 0.00% |
Renaissance Technologies | 659,300 | $1,319 | 0.00% |
Aptus Capital Advisors, LLC | 16,760 | $33,520 | 0.00% |
Connor, Clark & Lunn Investment Management Ltd. | 115,539 | $231,078 | 0.00% |
Sculptor Capital LP | 37,000 | $74,000 | 0.00% |
Sculptor Capital LP | 37,000 | $74,000 | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 303,800 | $559,785 | 0.00% |
Verition Fund Management LLC | 54,474 | $108,948 | 0.00% |
BANK OF AMERICA CORP /DE/ | 70,764 | $141,528 | 0.00% |
External links
This page lists PROTALIX BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view PROTALIX BIOTHERAPEUTICS INC's shareholder history, click here.